Beam Therapeutics (BEAM) Interest Coverage Ratio (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Interest Coverage Ratio data on file, last reported at 111.68 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 89.23% year-over-year to 111.68 in Q1 2026; TTM through Mar 2026 was 7.68, a 99.79% increase from a year earlier, with the FY2025 full-year figure at 7.13, down 651.5% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 111.68, up from 9754.69 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for BEAM reached as high as 5.91 in Q4 2023 and fell as low as 53252.0 in Q3 2024.
• Historically, Interest Coverage Ratio has averaged 4337.5 across 5 years, with a median of 233.32 in 2023.
• Across the five-year window, Interest Coverage Ratio surged 100.51% in 2023 and tumbled 23804.3% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 1170.86 in 2022, then surged by 100.51% to 5.91 in 2023, then plunged by 167.79% to 4.01 in 2024, then sank by 243179.8% to 9754.69 in 2025, then surged by 98.86% to 111.68 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 111.68 in Q1 2026, 9754.69 in Q3 2025, and 2310.6 in Q2 2025.